An update on the pathological classification of breast cancer-Reference-Cited by-同舟云学术

An update on the pathological classification of breast cancer

Published:2022-12-08 Issue:1 Volume:82 Page:5-16
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Rakha Emad A¹²^ORCID,Tse Gary M³^ORCID,Quinn Cecily M⁴^ORCID

Affiliation:

1. Translational Medical Sciences Unit, School of Medicine University of Nottingham Nottingham UK

2. Department of Cellular Pathology Nottingham University Hospitals NHS Trust, Nottingham City Hospital Nottingham Nottingham UK

3. Department of Anatomical and Cellular Pathology Prince of Wales Hospital, The Chinese University of Hong Kong Ngan Shing Street Shatin NT Hong Kong SAR

4. Department of Histopathology St. Vincent's University Hospital Dublin Ireland

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14786

Reference83 articles.

1. Understanding breast cancer – The long and winding road

2. Further Studies on Prognosis of Breast Carcinoma

3. Prognostic factors in cancer of the female breast. II.Reproducibility of histopathologic classification

4. Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries

5. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer;Frontiers in Oncology;2024-08-29

2. Hierarchical Learning-Enhanced Chaotic Crayfish Optimization Algorithm: Improving Extreme Learning Machine Diagnostics in Breast Cancer;Mathematics;2024-08-26

3. Rationale for the Initiation, Outcomes, and Characteristics of Chemotherapy Following CDK4/6 Inhibitors in Breast Cancer: A Real-World Cohort Study;Cancers;2024-08-20

4. Clinicopathologic significance of heat shock protein 60 as a survival predictor in breast carcinoma;Frontiers in Oncology;2024-08-19

5. Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-08-18